Bilimsel çalışmalar

Prof. Dr. Mutlu Demiray

87 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. E. Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitaplarında Basılan Bildiriler

    Kaynak: medicana.com.tr profil sayfası

  2. (Yukarıdaki maddelerde yer alan başlıklardaki kategorilere girmeyen ve belirtilmek istenen tüm eserler bu maddenin altında belirtilecektir.)

    Kaynak: medicana.com.tr profil sayfası

  3. B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında (Proceedings) basılan bildiriler

    Kaynak: medicana.com.tr profil sayfası

  4. DNA Repair Deficiency: A Series of 8 Patients. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420969812. doi: 10.1177/1534735420969812. PMID: 33150793.

    Kaynak: medicana.com.tr profil sayfası

  5. A2. Bahadori F, Demiray M. Management of extravasation of oxaliplatin by mimicking its biotransformation. Clin Transl Oncol. 2018 Oct;20(10):1353-1357. doi: 10.1007/s12094-018-1854-z. Epub 2018 Apr 27. PMID: 29704231.

    Kaynak: medicana.com.tr profil sayfası

  6. A3. Sahinbas H, Rosch M, Demiray M. Temperature measurements in a capacitive system of deep loco-regional hyperthermia. Electromagn Biol Med. 2017;36(3):248-258. doi: 10.1080/15368378.2017.1307221. Epub 2017 Apr 27. PMID: 28448752.

    Kaynak: medicana.com.tr profil sayfası

  7. A4. Bahadori F, Demiray M. A Realistic View on "The Essential Medicinal Chemistry of Curcumin". ACS Med Chem Lett. 2017 Sep 14;8(9):893-896. doi: 10.1021/acsmedchemlett.7b00284. PMID: 28947929; PMCID: PMC5601379.

    Kaynak: medicana.com.tr profil sayfası

  8. A5. Demiray M, Sahinbas H, Atahan S, Demiray H, Selcuk D, Yildirim I, Atayoglu AT. Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report. Complement Ther Med. 2016 Aug;27:108-13. doi: 10.1016/j.ctim.2016.06.009. Epub 2016 Jul 1. PMID: 27515884.

    Kaynak: medicana.com.tr profil sayfası

  9. A6. Arican A, Bozkurt T, Bozcuk H, Demirkan B, Buyukberber S, Alkis N, Sanli UA, Camci C, Yildiz M, Yucel I, Uygun K, Aslay I, Demiray M, Bese NS, Isikdogan A, Bahat Z, Gemici C, Ozdemir F, Ozdener F, Pekin B. A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey. Support Care Cancer. 2014 Oct;22(10):2629-34. doi: 10.1007/s00520-014-2253-9. Epub 2014 Apr 22. PMID: 24752566; PMCID: PMC4153980.

    Kaynak: medicana.com.tr profil sayfası

  10. A7. Demiray M, Ulukaya EE, Arslan M, Gokgoz S, Saraydaroglu O, Ercan I, Evrensel T, Manavoglu O. Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study. Cancer Invest. 2006 Nov;24(7):669-76. doi: 10.1080/07357900600981307. PMID: 17118776.

    Kaynak: medicana.com.tr profil sayfası

  11. A8. Demiray M, Kurt E, Evrensel T, Kanat O, Arslan M, Saraydaroglu O, Ercan I, Gonullu G, Gokgoz S, Topal U, Tolunay S, Tasdelen I, Manavoglu O. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure. Cancer Invest. 2005;23(5):386-91. doi: 10.1081/cnv-67133. PMID: 16193637.

    Kaynak: medicana.com.tr profil sayfası

  12. A9. Demiray M, Gulten M, Manavoglu O, Evrensel T, Ulukaya E, Yerci O, Kanat O, Kurt E, Arslan M, Gonullu G, Demiray H, Gulten T, Memik F. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. Hepatogastroenterology. 2004 Sep-Oct;51(59):1531-5. PMID: 15362794.

    Kaynak: medicana.com.tr profil sayfası

  13. A10. Gulten T, Tokyay N, Demiray M, Gulten M, Ercan I, Evke E, Sardas S, Karakaya AE. The role of triple therapy, age, gender and smoking on the genotoxic effects of Helicobacter pylori infection. J Int Med Res. 2002 Jul-Aug;30(4):380-5.

    Kaynak: medicana.com.tr profil sayfası

  14. A11. Arslan M, Evrensel T, Kurt E, Demiray M, Ercan I, Kanat O, Ozkan A, Manavoglu O. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients. Neoplasma. 2005;52(1):43-5.

    Kaynak: medicana.com.tr profil sayfası

  15. A12. Arslan M, Evrensel T, Kurt E, Demiray M, Gonullu G, Kanat O, Manavoglu O. Comparison of clinical outcomes of different erythropoietin usage strategies. Tumori. 2004 Jul-Aug;90(4):394-8.

    Kaynak: medicana.com.tr profil sayfası

  16. A13. Kanat O, Evrensel T, Kurt E, Demiray M, Gonullu G, Arslan M, Manavoglu O. Treatment of metastatic pancreatic cancer with a combination of gemcitabine and 5-fluorouracil: a single center phase II study. Tumori. 2004 Mar-Apr;90(2):192-5.

    Kaynak: medicana.com.tr profil sayfası

  17. A14. Kanat O, Evrensel T, Manavoglu O, Demiray M, Kurt E, Gonullu G, Kiyici M, Arslan M. Single agent irinotecan as second-line treatment for advanced gastric cancer. Tumori. 2003 Jul-Aug;89(4): 405-7.

    Kaynak: medicana.com.tr profil sayfası

  18. A15. Kanat O, Adim S, Evrensel T, Yerci O, Ediz B, Kurt E, Demiray M, Gonullu G, Arslan M, Manavoglu O.Prognostic value of nm23 in gastrointestinal stromal tumors. Med Oncol. 2004; 21(1): 53-8.

    Kaynak: medicana.com.tr profil sayfası

  19. A16. Kurt E, Sezgin C, Evrensel T, Yalcinkaya U, Kanat O, Veral A, Demiray M, Arslan M, Karabulut M, Ercan I, Goker E, Manavoglu O. Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary carcinoma Int J Clin Pract. 2005 May;59(5):537-43.

    Kaynak: medicana.com.tr profil sayfası

  20. A17. Kanat O, Evrensel T, Baran I, Coskun H, Zarifoglu M, Turan OF, Kurt E, Demiray M, Gonullu G, Manavoglu O. Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer: a single center randomized study. Med Oncol. 2003;20(3):237-45.

    Kaynak: medicana.com.tr profil sayfası

  21. A18. Kanat O, Evrensel T, Adim SB, Yavascaoglu I, Kurt E, Demiray M, Gonullu G, Manavoglu O. Small cell carcinoma of the urinary bladder. A clinicopathologic study of five cases. Tumori. 2003 MayJun;89(3):328-30.

    Kaynak: medicana.com.tr profil sayfası

  22. A19. Alper E, Gurel M, Evrensel T, Ozkocaman V, Akbunar T, Demiray M.99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy. Nucl Med Commun. 2003 May;24(5):537-42.

    Kaynak: medicana.com.tr profil sayfası

  23. A20. Kanat O, Evrensel T, Demiray M, Kurt E, Gonullu G, Arslan M, Manavoglu O, Ozkan A. Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older. Lung Cancer. 2003 Aug;41(2):233-4.

    Kaynak: medicana.com.tr profil sayfası

  24. A21. Kanat O, Evrensel T, Kurt E, Arslan M, Demiray M, Aker S, Manavoglu O. Successful treatment of thymoma-associated erythroid hypoplasia and thrombocytopenia with paclitaxel. Clin Oncol (R Coll Radiol). 2005 Feb;17(1):68

    Kaynak: medicana.com.tr profil sayfası

  25. A22. Tasdelen I, Gokgoz S, Paksoy E, Yerci O, Cetintas SK, Demiray M, Samsa V. Acquired lymphangiectasis after breast conservation treatment for breast cancer: report of a case. Dermatol Online J. 2004 Jul 15;10(1):9.

    Kaynak: medicana.com.tr profil sayfası

  26. A23. Ozkan K, Turkkan E, Ender K, Mutlu D, Murat A, Nalan B, Abdulmecit Y, Osman M. 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: a retrospective analysis of 68 patients. Indian J Cancer. 2005 Apr-Jun;42(2):85-8.

    Kaynak: medicana.com.tr profil sayfası

  27. B1. Disel U, Kose F, Bilici A, Özgüroğlu M, Saglam S, Seker M, Aksoy S, Tek I, Eralp Y, Mandel NM, Demir G, Arslan C, Demiray M, Salepci T, Ozturk MA, Biricik FS, Temizas G, Fidan EG. Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study. Journal of Clinical Oncology 38 (15_suppl), e13646-e13646. 2020/5/20

    Kaynak: medicana.com.tr profil sayfası

  28. B2. Can Curcumin be Employed to Promote the Integration of Oncology and Natural Products? Demiray M, Bahadori F. Proceedings 2017, 1(10), 980.

    Kaynak: medicana.com.tr profil sayfası

  29. B3. Sevim B. B. , Çerçi B. H. , Küçük Z., BAHADORİ F., Kazdal F., Eskandari Z., Tırıs G., DEMIRAY M. Optimization of a new controlled release oral dexketoprofen formulation. 24th World Nano Conference, Roma, İtalya, 07 May 2018, ss.1

    Kaynak: medicana.com.tr profil sayfası

  30. B4. Demiray M. Can Curcumin overcome cancer chemoresistance. 5th International Meeting on Complementary & Alternative Medicine and Therapies September 18-19, 2017 Charlotte, USA

    Kaynak: medicana.com.tr profil sayfası

  31. B5. Demiray M. CURCUMIN: A potential new therapeutic option in Head & Neck Carcinoma. BIT's 10th Annual World Cancer Congress -2017 (WCC-2017) will be held on 19-21, May 2017 in Barcelona, Spain.

    Kaynak: medicana.com.tr profil sayfası

  32. B6. Demiray M, Sahinbas H. Hyperthermia , Chemotherapy and Curcumin treatment modality is safe and may be more effective strategy for cancer treatment. V. Hyperthermia Symposium Köln 3-4 october 2015

    Kaynak: medicana.com.tr profil sayfası

  33. B7. Demiray M, Manavoglu O, Evrensel T, Tasdelen I, Tolunay S, Kurt E, Kanat O, Gonullu G. The response rates of two different dosages of epirubicin in neoadjuvant chemotherapy of locally advanced breast cancer: High dose vs low dose ? ASCO 2003 Proc Am Soc Clin Oncol 22: page 81, 2003 (abstr 322)

    Kaynak: medicana.com.tr profil sayfası

  34. B8. Demiray M, Gülten M, Kurt E, Evrensel T, Kanat O, Ulukaya E, Gonullu G, Manavoglu O. Relationship of Helicobacter Pylori status and gastric epithelial proliferation. 11th World Congress of surgeons&gastroenterologists, Hepato-Gastroenterology, 2001;48(suppl 1): p108.

    Kaynak: medicana.com.tr profil sayfası

  35. B9. Demiray M, Kurt E, Gülten M, Evrensel T, Kanat O, Izgi B, Gonullu G, Manavoglu O.Relationship of Helicobacter Pylori status and serum selenium and malondialdehyde levels. 11th World Congress of surgeons&gastroenterologists, Hepato-Gastroenterology, 2001;48(suppl 1): p109.

    Kaynak: medicana.com.tr profil sayfası

  36. B10. Gonullu G, Kurt E, Evrensel T, Demiray M, Kanat O, Yilmazlar T, Manavoglu O. Our treatment results of rectum melanoma. 11th World Congress of surgeons&gastroenterologists, HepatoGastroenterology 2001;48(suppl 1): p144.

    Kaynak: medicana.com.tr profil sayfası

  37. B11. Gonullu G, Kurt E, Evrensel T, Kanat O, Demiray M, Yerci O, Manavoglu O Primary gastric lymphomas: Clinical features and results of therapy.. 11th World Congress of surgeons&gastroenterologists, Hepato-Gastroenterology 2001;48(suppl 1): p145.

    Kaynak: medicana.com.tr profil sayfası

  38. B12. Kanat O, Kurt E, Evrensel T, Demiray M, Gonullu G, Manavoglu O. Malignant gastrointestinal tumors: Clinical features and results of therapy. 11 t h Wo r l d C o n g r e s s o f surgeons&gastroenterologists, Hepato-Gastroenterology 2001;48(suppl 1): p142.

    Kaynak: medicana.com.tr profil sayfası

  39. B13. Kurt E, Kanat O, Evrensel T, Demiray M, Arslan M, Gonullu G, Manavoglu O. A phase II study of gemcitabine plus 5-fluorouracil in patients with advanced pancreatic cancer. 11th World Congress of surgeons&gastroenterologists, Hepato-Gastroenterology 2001;48(suppl 1): p132.

    Kaynak: medicana.com.tr profil sayfası

  40. B14. Kurt E, Evrensel T, Dilek K, Filiz G, Gonullu G, Kanat O, Arslan M, Demiray M, Manavoglu O. Effects of two different doses of recombinant human erythropoietin (rHuEPO) on cisplatin-induced acute renal failure. Program/Proceedings, ASCO-Thirty-Eighth Annual Meeting, May 18-21, 2002, Orlando, FL, P1842.

    Kaynak: medicana.com.tr profil sayfası

  41. B15. Arslan M, Kurt E, Evrensel T, Gonullu G, Kanat O, Demiray M, Ali R, Manavoglu O. Comparison of the serum erythropoietin levels in chemotherapy-naïve and cisplatin-treated cancer patients. 27th ESMO Congress, 18-22 October, 2002, Nice-France. P73.

    Kaynak: medicana.com.tr profil sayfası

  42. B16. T. Gulten, M. Demiray M, İ. Ercan, M.Gülten, R. Tokyay. Standart eradication therapy reduces the DNA damage in Helicobacter pylori infected patient. Eurosurgery 2000, İstanbul, 2000

    Kaynak: medicana.com.tr profil sayfası

  43. B17. Kurt E, Demiray M, Kanat O, Evrensel T, Arslan M, Gonullu G, Yilmazlar T, Manavoglu O. Gastrointestinal cancers associated with other primary cancers. 11th World Congress of surgeons&gastroenterologists, Hepato-Gastroenterology 2001;48(suppl 1): p133.

    Kaynak: medicana.com.tr profil sayfası

  44. B18. Gonullu G, Kurt E, Evrensel T, Kanat O, Demiray M, Tasdelen I, Manavoglu O. Neoadjuvant chemotherapy for breast cancer: Results of a single institute experience. 27th ESMO Congress, 18-22 October, 2002, Nice-France. P226

    Kaynak: medicana.com.tr profil sayfası

  45. B19. Kanat O, Kurt E, Evrensel T, Demiray M, Ozkan A, Gonullu G, Manavoglu O. Fluorouracil, Epirubicin and Cisplatin (FEP) in locally advanced or metastatic gastric cancer. 12th World Congress of International Association of Surgeons&Gastroenterologists, October 30-November 2, 2002, Istanbul. PP339.

    Kaynak: medicana.com.tr profil sayfası

  46. B20. Gonullu G, Kurt E, Evrensel T, Kanat O, Demiray M, Manavoglu O. Clinical features and treatment result of gastrointestinal system (GIS) lymphoma. 12th World Congress of International Association of Surgeons&Gastroenterologists, October 30-November 2, 2002, Istanbul. PP353.

    Kaynak: medicana.com.tr profil sayfası

  47. B21. Gonullu G, Kurt E, Evrensel T, Demiray M, Kanat O, Manavoglu O. FEP regimen in the treatment of hepatocellular and biliary tract carcinoma. 12th World Congress of International Association of Surgeons&Gastroenterologists, October 30-November 2, 2002, Istanbul. PP348.

    Kaynak: medicana.com.tr profil sayfası

  48. B22. Gonullu G, Kurt E, Evrensel T, Kanat O, Demiray M, Arslan M, Kiyici M, Yilmazlar T, Manavoglu O. Second-Line 5-fluorourocil+folinic acid+irinotecan chemotherapy in colorectal cancer patients. 12th World Congress of International Association of Surgeons&Gastroenterologists, October 30November 2, 2002, Istanbul. PP347.

    Kaynak: medicana.com.tr profil sayfası

  49. B23. Tuna Gülten, Tokyay N, Demiray M, Ercan I, Evke E, Gülten M, Sardas S, Karakaya E.A. The role of age, gender and smoking on helicobacter pylori’s genetoxic effect and on the efficacy of the eradication therapy. Europan Human Genetics Conference 2000.

    Kaynak: medicana.com.tr profil sayfası

  50. B24. Yakut T, Demiray M, Çalışkan Z, Gülten T. HER2/neu gene amplification in muscle invasive bladder cancer; FISH analysis on paraffin-embedded specimens. EUROPEAN HUMAN GENETICS CONFERENCE 2005 Center, Prague, Czech Republic May 7 - 10, 2005. P0533.

    Kaynak: medicana.com.tr profil sayfası